What drove the after-hours move in 1B1.SI stock today?

The after-hours uptick to S$0.365 was driven by higher trading volume of 30,900 shares and short-term buying pressure. Market participants cited attractive valuation—P/E 7.30—and the stock’s dividend yield near 5.42% as reasons to buy into the Healthcare name.

How does Meyka AI rate 1B1.SI and what does the grade mean?

Meyka AI rates 1B1.SI with a score out of 100: 66.97, Grade B — HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. It is informational, not investment advice.

What is the short-term price forecast for 1B1.SI stock?

Meyka AI's forecast model projects a monthly target of S$0.39 and a quarterly target of S$0.37. The monthly target implies about **6.85%** upside versus the current price S$0.365. Forecasts are model-based projections and not guarantees.

SG Stocks

S$0.365 HC Surgical (1B1.SI SES) +4.29% after hours 15 Jan 2026: monitor volume

ByHuzaifa Zahoor January 15, 2026

The 1B1.SI stock moved to S$0.365 in after-hours trade on 15 Jan 2026, up 4.29% from the previous close on the Singapore Exchange (SES). Volume accelerated to 30,900 shares versus an average daily volume of 32,583, marking this name as a high-volume mover in the Healthcare sector. Traders are watching near-term technical levels — day high S$0.370 and year high S$0.375 — while fundamentals show a low P/E and a dividend yield that supports income-focused investors. We outline key drivers, Meyka AI grade, and a short-term forecast to inform trading and investment decisions.